Acuity Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Acuity Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$39K	Sell	600 -100	-14%	-$6.26K	0.06%	139
2014 Q4	$41K	Hold	700	–	–	0.03%	149
2014 Q3	$36K	Hold	700	–	–	0.03%	151
2014 Q2	$34K	Sell	700 -2,500	-78%	-$123K	0.02%	150
2014 Q1	$166K	Sell	3,200 -2,400	-43%	-$128K	0.09%	111
2013 Q4	$298K	Sell	5,600 -56,600	-91%	-$2.88M	0.12%	106
2013 Q3	$2.87M	Buy	+62,200	New	+$2.73M	0.39%	59

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Acuity Investment Management's BMY Position: Q1 2015 in Review

Acuity Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2015, selling an estimated $6.26K and leaving 600 shares worth $39K. The position accounts for 0.06% of the portfolio, ranked #139.

Acuity Investment Management first reported a position in BMY in Q3 2013 and has held it in 7 quarters since. The position peaked at $2.87M in Q3 2013. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Acuity Investment Management held 600 shares of Bristol-Myers Squibb worth $39K as of Q1 2015.
Acuity Investment Management sold 100 Bristol-Myers Squibb shares in Q1 2015, an estimated $6.26K.
Bristol-Myers Squibb made up 0.06% of Acuity Investment Management's portfolio in Q1 2015, its #139 holding.
Acuity Investment Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 7 quarters since.
Acuity Investment Management's Bristol-Myers Squibb position peaked at $2.87M in Q3 2013.
1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Acuity Investment Management's 13F filing for Q1 2015, filed 11 May 2015.